Patent details

92128 Product Name: 8-(3-Aminopiperidin-1-yl)-7-but-2-inyl-3-methyl-1-(4-methylchinazolin-2-ylmethyl)-3, 7-dihydropurin-2, 6-dion, les énantiomères et leurs sels, en particulier la Linagliptine* combinée avec du chlorhydrate de metformine.*Linagliptine=((R)-8-(3-Aminopiperidin-1-yl)-7-but-2-inyl-3-methyl-1-(4-methylchinazolin-2-ylmethyl)-3, 7-dihydropurin-2, 6-dion) (IUPAC)

Basic Information

Publication number:
92128
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP037923596
Legal Status:
Lapsed
Application number:
92128
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/12/780/001-028
Marketing Authorization Type:
Marketing Authorization Date:
20/07/2012
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
09/01/2013
First Marketing Authorization date:
20/07/2012
Grant date:
11/03/2013
Activation date:
18/08/2023
Publication date:
11/03/2013
Lapsed date:
Expiration date:
Renunciation date:
25/05/2016
Revocation date:
Annulment date:
Basic SPC Expiration:
20/07/2027
SPC Extension Expiration:
20/07/2027
Rejection date:
Withdrawal date:

Owner

From:
09/01/2013
 
 

Name:
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG
Address:
-, 55216, INGELHEIM AM RHEIN, Germany (DE)

Agent

Name:
ARONOVA S.A.
From:
09/01/2013
Address:
PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)
To:

Inventor

1

Name:
MARK Michael
Address:
Germany (DE)

2

Name:
LOTZ Ralf, Richard, Hermann
Address:
Germany (DE)

3

Name:
ECKHARDT Matthias
Address:
Germany (DE)

4

Name:
LANGKOPF Elke
Address:
Germany (DE)

5

Name:
HIMMELSBACH Frank
Address:
Germany (DE)

6

Name:
MAIER Roland
Address:
Germany (DE)

7

Name:
TADAYYON Mohammad
Address:
United Kingdom (GB)

Other

Note:
Renonciation au CCP enregistrée le 25/05/2016 / SPC renunciation registered on 25/05/2016
Filing date Document type Number of pages